Brief Description
EnVoy-LAB is advancing next-generation production of life-saving medical radioisotopes for contract development and manufacturing organizations (CDMOs), radiopharmacies, pharmaceutical companies, and healthcare systems.
The company is developing novel cyclotron-based methods for producing Actinium-225 and Lead-212, two of the most promising isotopes for targeted alpha therapy. EnVoy-LAB's technologies enable decentralized, scalable, and high-purity isotope production using existing standard cyclotrons, increasing supply for transformative cancer treatments.
Inventors
Lee Allen Bernstein, Dajie Sun, Andrew S. Voyles, Rebecca J. Abergel
Company Founders
Lee Allen Bernstein, Andrew S. Voyles, Candace Fleming
Timeline
- 2025. Company founded